• We offer tailored partnerships to support and transform drug discovery.

    Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

  • MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

    As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

  • Our OrganoReady program is made for you when you need optimized assays for investigational toxicology.

    We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

  • Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.
  • Get inspired by research done by our scientists, partners, and customers around the globe.

  • Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.
open menu icon close menu icon
EN

Poster: ALS-On-A-Chip:Towards Patient-Derived Models for Personalized Therapy Development

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease in which upper and lower motor neurons undergo progressive degeneration leading to muscle denervation, paralysis, and death within 3–5 years after diagnosis. The exact causes remain unknown, but aberrances in axonal stability, axonal transport, and axon growth dynamics have been reported amongst other hallmarks. Although traditional 2D cultures and in vitro platforms have shown to be invaluable for studying neurite outgrowth and regeneration, they lack in uncovering ALS disease mechanisms and do not allow for directed neurite outgrowth and separation of cell somata and neurites, which is of major interest in studying motor axon biology. Microfluidic systems can be the solution as they provide excellent spatial control of cells and matrices, and are routinely used to study axon outgrowth.

In this poster, we present a 3D neurite outgrowth model using iPSC-derived motor neurons and demonstrate that this model is suitable for studying nerve damage that is compound-induced or resulting from disease. Here, we highlight that the OrganoPlate® platform is ideal to study toxic effects on periperal neurons and captures ALS-relevant processes, and that it is functional for studying axonal biology and disease and subsequent therapy development.

 

 

Download the poster here

Cookies

May we use cookies?
Hi there! Thanks for visiting our website. We use cookies to keep track of our website statistics to optimize the user experience. We also use cookies for marketing purposes. You can set your preferences by selecting the options below. Terms of Use & Privacy Policy
Accept all
Accept selected
Decline all